Copaxone®

Prof. Michael Sela

Copaxone® - MS medication

10.10.2010

Benefiting Humanity, Diagnostic Techniques and Drugs

from the institute to Teva Pharmaceuticals Ltd.

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

23.12.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

19.09.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...

Top Stories

Staphylococcus bacteria

New Immune Mechanism Revealed in the Cellular Trash

When Proteins Go on Strike

Mouse heart tissue viewed under a microscope

A Broken Heart: Two Types of Scars, Two Paths to Healing

Seeding the Passion

Press Releases

New Immune Mechanism Revealed in the Cellular Trash

A Broken Heart: Two Types of Scars, Two Paths to Healing

Training Future Physician-Scientists: The Weizmann Institute Receives Approval for a New Medical School

Most Popular Articles

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research

The Limits of Computing

Computers can solve complex problems but they are far from omnipotent. Prof. Ran Raz of the Weizmann Institute's Computer Science and Applied Mathematics Department is trying to portray the limits...